Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial
| Autor: | Das, Rituparna, Blázquez-Gamero, Daniel, Bernstein, David I, Gantt, Soren, Bautista, Oliver, Beck, Karen, Conlon, Anthony, Rosenbloom, Daniel I S, Wang, Dai, Ritter, Michael, Arnold, Beth, Annunziato, Paula, Russell, Kevin L * |
|---|---|
| Zdroj: | In The Lancet Infectious Diseases December 2023 23(12):1383-1394 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|